相关实验视频
Updated: May 5, 2026

07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
19.1K
范科米辛药物反应与埃索诺菲利亚和系统性症状:元分析和药监测研究
Mohammed Aboukaoud1, Yotam Adi2, Mahmoud Abu-Shakra1,3
1Department of Clinical Pharmacology, Faculty of Health Sciences, Ben-Gurion University, Beer Sheva 8410101, Israel.
Journal of clinical medicine
|February 13, 2025
概括
药物反应与埃索诺菲利亚和全身症状 (DRESS) 是严重的. 范科米辛是显著的原因,发病率与种族有关,而不是HLA-A*32:01等位基因频率.
科学领域:
- 药物监督 药物监督 药物监督
- 皮肤病学 皮肤病学
- 遗传学 遗传学 是一个
背景情况:
- 药物反应与埃索诺菲利亚和全身症状 (DRESS) 是一种严重的,可能致命的皮肤药物反应.
- 由于感染和药物特定变异的重叠症状,诊断具有挑战性.
- 缺乏意识有助于诊断困难.
研究的目的:
- 调查与万科米相关的DRESS的发病率和风险因素.
- 探索DRESS与不同种族的HLA-A*32:01等位基因之间的相关性.
- 评估同时使用抗微生物药物对DRESS风险的影响.
主要方法:
- 对RegiSCAR得分的观察性研究和FDA不良事件报告系统 (FAERS) 数据的元分析.
- 根据种族进行分组分析,以确定DRESS比例.
- 分析HLA等位基频率数据来自等位基频率净数据库 (AFND).
主要成果:
- 分析了1949个菌素-DRESS病例和2558个抗菌药物DRESS报告.
- 发现27%的万科米辛-DRESS发病率,高加索人 (36%) 的发病率最高. 平均延迟时间为21天.
- 香草素-DRESS发病率与HLA-A*32:01没有相关;香草素调整后的ROR为2.40.
结论:
- 香草素是DRESS发病率的重要贡献者,种族比HLA-A*32:01等位基因频率发挥更大的作用.
- 同时使用抗微生物药物会增加DRESS风险.
- 尽量减少抗微生物药物的使用对于更好的患者结果至关重要.
相关概念视频
Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Drug Toxicity: Allergic Reactions
223
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
223
Hypersensitivity Reactions: Cytolytic Reactions
221
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
221
Drug toxicity: Idiosyncratic Reactions
232
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
232
Hypersensitivity Reactions: Immune-Complex Reactions
286
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
286

